Browse All

Current Filters

CLEAR FILTER x

TITLE

Levodopa Initiation or Dose Adjustments in TEMPO-4: A 58-Week Open-label Trial of Tavapadon for Treatment of PD

Author:Ondo, William   Hatcher, Meredith   Soileau, Michael   Eubanks, James   Nicholson, Tracy   Dhall, Rohit   

Session Name:S26: Movement Disorders: Clinical Trials and Therapeutics  

Topic:Movement Disorders  

Program Number:S26.007  

Author Institution:Houston Methodist Neurological Institute, Weill Cornell Medical School, Houston, TX  Texas Movement Disorder Specialists, Georgetown, TX  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  AbbVie, Inc., North Chicago, IL  University of Arkansas for Medical Sciences, Little Rock, AR  

Impact on Tremor in Phase Three Trials of Tavapadon: A Selective D1/D5 Agonist for Treatment of Parkinson’s Disease

Author:Torres-Russotto, Diego   Harmer, Linda   Nicholson, Tracy   Bhatia, Perminder   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.005  

Author Institution:Baptist Health South Florida Miami Neuroscience Institute, Miami, FL  AbbVie, Inc., North Chicago, IL  Neuro Pain Medical Center, FRESNO, CA